Malaria drug considered for COVID-19 may raise risk of heart problems, scientists say


PTI, Apr 3, 2020, 12:52 PM IST

New Delhi: The anti-malaria drug hydroxychloroquine and the antibiotic azithromycin, which are being considered by some for treating COVID-19, may increase the risk for dangerous abnormal heart rhythms, US cardiologists have warned.

The researchers from Oregon Health & Science University (OHSU) and Indiana University recommend that clinicians treating COVID-19 patients with the malaria-antibiotic drug combination should consider monitoring those patients for ventricular arrhythmia.

“The condition leads to the lower heart chambers beating quickly and irregularly, and can lead to cardiac arrest,” they said.

In a paper published in the American College of Cardiology’s Cardiology Magazine, the researchers noted that there are hundreds of drugs that can increase the risk for cardiac arrest.

However, they said that using two together in patients who are already at risk or critically ill could increase that risk further.

“While there is yet very little data regarding hydroxychloroquine and azithromycin’s effectiveness as a treatment for COVID-19, some clinicians are considering combining them during this global pandemic,” said Eric Stecker, the paper’s lead author.

“If physicians use their best medical judgment and order this drug combination for coronavirus patients, we want them to be aware of potential adverse side effects,” said Stecker, an associate professor at the OHSU School of Medicine.

The researchers recommend clinicians who treat COVID-19 patients with the drug combination also monitor patients for dangerous arrhythmias.

However, they acknowledged that limited resources could make monitoring a challenge.

“Until we have clinical outcome data supporting the benefit or harm of these medications, I would advocate for a cautious approach in using the combination of hydroxychloroquine and azithromycin,” Stecker said.

“Any medications that increase the risk of cardiac risk require consideration of both risks and benefits, and right now we do not have evidence that benefits outweigh risks for use of hydroxychloroquine or chloroquine,” he said.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Karnataka invites UK varsity to set up campus in Bengaluru

I will play IPL next year, will be unfair not to say thank you to Chennai: MS Dhoni

Chhattisgarh: Woman jumps into Chitrakote waterfall, video goes viral

Ram Temple idol installation in Jan 2024: Vishwaprasanna Teertha Swamiji of Pejawar Matha

Prepared for BBMP elections, welcome SC order: Karnataka CM

Gang of international smugglers held with 218 kg of heroin worth Rs 1,500 crore off Lakshadweep coast

Bommai to participate in annual meet of World Economic Forum in Switzerland


Related Articles More

Psychedelics: how they act on the brain to relieve depression

Can sniffer dogs really detect COVID almost as well as a PCR test? Turns out they can

Glenmark Pharma gets final USFDA nod for generic version of Abiraterone Acetate tabs

Natural immunity from Omicron infection weak, limited, study finds

Colours and their Language

MUST WATCH

The success formula of dairy farming

SSC Result : Sirsi Governament School Students Achivement

Important Health Tips Must Watch

NEWS BULLETIN 19-05-2022

Storks enjoy agriculture activity


Latest Additions

Karnataka invites UK varsity to set up campus in Bengaluru

I will play IPL next year, will be unfair not to say thank you to Chennai: MS Dhoni

Udupi: 45-year-old man ventures out at night, goes missing

Chhattisgarh: Woman jumps into Chitrakote waterfall, video goes viral

K’taka to implement welfare programmes for SC/STs

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.